Insider Selling: Doximity, Inc. (NASDAQ:DOCS) Director Sells $25,820.94 in Stock

Doximity, Inc. (NASDAQ:DOCS) Director Watkin Phoebe L. Yang sold 1,011 shares of the company’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the transaction, the director now directly owns 11,258 shares in the company, valued at $287,529.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Doximity Trading Up 1.0 %

NASDAQ:DOCS traded up $0.26 during midday trading on Tuesday, hitting $26.25. 1,144,155 shares of the company were exchanged, compared to its average volume of 1,640,933. Doximity, Inc. has a fifty-two week low of $19.71 and a fifty-two week high of $34.56. The company has a market capitalization of $4.87 billion, a PE ratio of 35.94, a price-to-earnings-growth ratio of 5.12 and a beta of 1.22. The company has a fifty day simple moving average of $28.00 and a 200 day simple moving average of $27.38.

Doximity (NASDAQ:DOCS) last issued its quarterly earnings data on Thursday, May 16th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.04. Doximity had a net margin of 31.04% and a return on equity of 17.44%. The company had revenue of $118.06 million for the quarter, compared to the consensus estimate of $116.46 million. As a group, equities research analysts expect that Doximity, Inc. will post 0.74 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on DOCS. Needham & Company LLC reaffirmed a “hold” rating on shares of Doximity in a research report on Friday, May 17th. Evercore ISI upped their price target on shares of Doximity from $28.00 to $29.00 and gave the company an “in-line” rating in a report on Friday, May 17th. JPMorgan Chase & Co. raised shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price target on the stock in a report on Thursday, April 25th. William Blair reaffirmed an “outperform” rating on shares of Doximity in a report on Friday, May 17th. Finally, Morgan Stanley reaffirmed an “underweight” rating and issued a $25.00 price target on shares of Doximity in a report on Tuesday, April 23rd. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $28.00.

Institutional Trading of Doximity

Several hedge funds and other institutional investors have recently made changes to their positions in DOCS. William Blair Investment Management LLC purchased a new stake in shares of Doximity in the first quarter valued at about $148,823,000. Swedbank AB purchased a new stake in Doximity during the first quarter worth about $91,673,000. Norges Bank purchased a new stake in Doximity during the fourth quarter worth about $35,995,000. Capital World Investors boosted its holdings in Doximity by 250.7% during the first quarter. Capital World Investors now owns 1,714,707 shares of the company’s stock worth $46,143,000 after buying an additional 1,225,707 shares in the last quarter. Finally, Janus Henderson Group PLC raised its position in Doximity by 33.5% during the first quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock worth $66,594,000 after acquiring an additional 621,590 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.